'Torrent Pharma gets establishment nod from USFDA'. 'Torrent Pharma acquires US-based Bio-Pharm'.

^ 'Torrent Pharma Q1 net profit up 33 percent to Rs 216 crore'.

^ a b c d e f 'Torrent Pharmaceuticals Ltd.

In September 2019, the FDA issued notice of a sixth product recall of losartan by Torrent Pharmaceuticals when certain batches of losartan contained the contaminant, N-methylnitrosobutyric acid (NMBA), above acceptable daily intake levels determined by the FDA. In 2018, Torrent Pharmaceuticals recalled tablets containing valsartan and losartan due to the detection of N-nitrosodimethylamine (NDMA) and N-nitrosodiethylamine (NDEA) respectively which are probable human carcinogens.

Manufacturing plant at Visakhapatnam (Andhra Pradesh).

Corporate Office, beside sales India, off.

Research Centre, Ahmedabad- Gandhinagar region, Gujarat.

3 Manufacturing plant at Rang-Po,(Sikkim).

Manufacturing plant at Baddi, Himachal Pradesh.

Manufacturing plant at Indrad, Mehsana, Gujarat.

Manufacturing plant at Pithampur, Madhya Pradesh.

The company's key areas are Formulations, API, Drug Discovery, Marketing and Sales of Drugs. Torrent Pharmaceuticals acquired Heumann GmbH, a Pfizer company, in 2005.

Torrent Pharma Philippines Inc., Philippines.

Heumann Pharma GmbH & Co Generica KG, Germany.

Torrent Pharma Derma Products